Quisel John D's Form 4 filing
Disc Medicine, Inc. (IRON) · filed Jan 2, 2025
- Accession no.
- 0000950170-25-000617
- Filed
- Jan 2, 2025
- Trade date
- Dec 30-31, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $806.1K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Quisel John DCIK 0001586788 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 30, 2024 | Common Stock | MOption exerciseAcquired | +13,012 | $9.86 | +$128,298.32 | 85,077 | Direct | |
| Dec 30, 2024 | Common Stock | SSaleDisposed | −11,112 | $61.87 | −$687,499.44 | 73,965 | Direct | |
| Dec 30, 2024 | Common Stock | SSaleDisposed | −1,900 | $62.41 | −$118,579 | 72,065 | Direct | |
| Dec 31, 2024 | Common Stock | MOption exerciseAcquired | +10,000 | $1.01 | +$10,100 | 82,065 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 30, 2024 | Common Stock | MOption exerciseDisposed | −13,012 | $0.00 | $0 | 155,375 | Direct | |
| Dec 31, 2024 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 215,420 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.